Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NC-410 by NextCure for Ovarian Cancer: Likelihood of Approval
NC-410 is under clinical development by NextCure and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
NC-410 by NextCure for Endometrial Cancer: Likelihood of Approval
NC-410 is under clinical development by NextCure and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II...
NC-410 by NextCure for Solid Tumor: Likelihood of Approval
NC-410 is under clinical development by NextCure and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
NC-410 by NextCure for Colorectal Cancer: Likelihood of Approval
NC-410 is under clinical development by NextCure and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II...
NC-410 by NextCure for Cervical Cancer: Likelihood of Approval
NC-410 is under clinical development by NextCure and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II...
NC-410 by NextCure for Gastric Cancer: Likelihood of Approval
NC-410 is under clinical development by NextCure and currently in Phase II for Gastric Cancer. According to GlobalData, Phase II...